226 related articles for article (PubMed ID: 3933827)
21. T lymphocyte characteristics in bone marrow-transplanted patients. II. Analysis with monoclonal antibodies.
de Bruin HG; Astaldi A; Leupers T; van de Griend RJ; Dooren LJ; Schellekens PT; Tanke HJ; Roos M; Vossen JM
J Immunol; 1981 Jul; 127(1):244-51. PubMed ID: 6787124
[TBL] [Abstract][Full Text] [Related]
22. Clonal T-cell colony formation in agar culture: an attractive assay to test the T-cell depletion from bone marrow.
Farcet JP; Beaujean F; Cordonnier C; Pico J; Gourdin MF; Divine M; Bracq C; Bouguet J; Laurent G; Bernard A
Exp Hematol; 1986 Dec; 14(11):1011-4. PubMed ID: 3536543
[TBL] [Abstract][Full Text] [Related]
23. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
[TBL] [Abstract][Full Text] [Related]
24. Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis.
Small TN; Avigan D; Dupont B; Smith K; Black P; Heller G; Polyak T; O'Reilly RJ
Biol Blood Marrow Transplant; 1997 Jun; 3(2):65-75. PubMed ID: 9267666
[TBL] [Abstract][Full Text] [Related]
25. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation.
Wolf E; Harms H; Winkler J; Reulbach U; Kirchner T; Niedobitek G; Baumann I
Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956
[TBL] [Abstract][Full Text] [Related]
26. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].
Fu YW; Wu DP; Sun AN; Feng YF; Chang WR; Zhu ZL; Zhu P
Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):312-7. PubMed ID: 17877159
[TBL] [Abstract][Full Text] [Related]
27. Decreased hematopoietic accessory cell function following bone marrow transplantation.
Emerson SG; Sieff CA; Gross RG; Rozans MK; Miller RA; Rappeport JM; Nathan DG
Exp Hematol; 1987 Nov; 15(10):1013-21. PubMed ID: 2959495
[TBL] [Abstract][Full Text] [Related]
28. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
Yabe M; Yabe H; Hattori K; Hinohara T; Morimoto T; Kato S; Kusunoki A
Bone Marrow Transplant; 1994 Nov; 14(5):741-6. PubMed ID: 7889006
[TBL] [Abstract][Full Text] [Related]
29. [Elimination of leukemic CD34+ progenitor cells by using cytotoxic T lymphocytes specifically targeting WT1-derived peptide: an experimental study in vitro].
Gu WY; Chen ZX; Qiu GQ; Hu SY; Jia L; Wu W; He J; Cen JN; He B
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3401-6. PubMed ID: 19159569
[TBL] [Abstract][Full Text] [Related]
30. Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation.
Ramakrishnan S; Uckun FM; Houston LL
J Immunol; 1985 Nov; 135(5):3616-22. PubMed ID: 3900212
[TBL] [Abstract][Full Text] [Related]
31. Leukemic cell colony formation in soft agar by bone marrow cells and peripheral blood cells from untreated acute leukemia patients.
Dicke KA; Tindle SE; Davis FM; Jagannath S; Tucker S; Lilien M; van Leeuwen P; Verma DS; Vellekoop L
Exp Hematol; 1983 Apr; 11(4):341-50. PubMed ID: 6341080
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of lymphocyte subsets after autologous bone marrow transplantation with marrow treated by ASTA Z 7557 in acute leukemia: incidence of the in vitro treatment.
Le Blanc G; Douay L; Laporte JP; Dominh A; Deloux J; Najman A; Duhamel G; Gorin NC
Exp Hematol; 1986 Jun; 14(5):366-71. PubMed ID: 3519264
[TBL] [Abstract][Full Text] [Related]
33. The cellular composition of human lymph nodes after allogenic bone marrow transplantation: an immunohistological study.
Dilly SA; Sloane JP; Psalti IS
J Pathol; 1986 Nov; 150(3):213-21. PubMed ID: 3543275
[TBL] [Abstract][Full Text] [Related]
34. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
35. Immunological reconstitution after allogeneic and autologous bone marrow transplantation.
Harada M; Ueda M; Nakao S; Kondo K; Odaka K; Shiobara S; Matsue K; Mori T; Hattori K
Tokai J Exp Clin Med; 1985 Jun; 10(2-3):245-52. PubMed ID: 2939601
[TBL] [Abstract][Full Text] [Related]
36. Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics.
Porta MD; Rigolin GM; Alessandrino EP; Maiocchi M; Malcovati L; Vanelli L; Baratè C; Rumi E; Ciccone M; Cuneo A; Lazzarino M; Castoldi G
Eur J Haematol; 2004 Jan; 72(1):18-25. PubMed ID: 14962258
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow T cell colony-forming cells: studies of their origin and use in monitoring T cell-depleted bone marrow grafts.
Knott LJ; Levinsky RJ; Newland AC; Jones HM; Linch DC
Clin Exp Immunol; 1985 Dec; 62(3):561-9. PubMed ID: 3910318
[TBL] [Abstract][Full Text] [Related]
39. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
40. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]